Marwan Sabbagh: Why is Dementia Misdiagnosis So Common?
Being Patient Facebook PageCatching and accurately identifying a neurodegenerative disease like Alzheimer's or another form of dementia early can make all the difference in the world to...
Catching and accurately identifying a neurodegenerative disease like Alzheimer's or another form of dementia early can make all the difference in the world to...
On Friday, October 6th at 10:00 a.m. PT/1:00 p.m. ET, Leah Fisher joins Being Patient Live Talks to discuss her journey of dealing with...
Mild Cognitive Impairment (MCI) is associated with early stages of neurodegenerative diseases like Alzheimer’s and other dementias. Many people living with dementia cite symptoms...
On Friday, October 20th at 10:00 a.m. PT / 1:00 p.m. ET, artist, community advocate, and Atlantic Fellow for Health Equity Gloria Aguirre joins...
Navigating the holidays with dementia can be challenging, especially when it comes to travel. When designing a holiday trip, there are key strategies that...
The key to understanding Alzheimer’s disease could be in our genes. While the cause of Alzheimer's is still unknown, mounting research shows that carrying...
Hearing loss, especially if it is not addressed with hearing aids or other hearing care, can increase your likelihood for cognitive decline. Symptoms associated...
Xanax and other benzodiazepines (“benzos”) are often prescribed to treat symptoms like agitation, anxiety, and depression in people living with dementia. Yet, these drugs...
On Friday, December 1st at 2:00 p.m. PT/ 5:00 p.m. ET, classical music publicist, educator, performer, and dementia advocate Mary Lou Falcone joins Being...
Our scientific understanding of — and society's response to — dementia are constantly evolving. When Alzheimer’s first came into public consciousness in 1906, attitudes...
Award-winning dementia researcher and educator Dr. Nir Grossman joins Being Patient Live Talks on Thursday, December 21st at 10:00 a.m. PT/1:00 p.m. PT to...
The process of finding new treatments for Alzheimer's disease is one of trial and error — and every "failed" trial generates invaluable new data...